1-Ethyl-3-methyl-5-methylsulfanylbenzene

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 1-Ethyl-3-methyl-5-methylsulfanylbenzene
• 英文别名: 1-ethyl-3-methyl-5-methylsulfanylbenzene
• 化学式: C₁₀H₁₄S
• 分子量: 166.29
• InChiKey: OPLVGFIEEKVVQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• PYRAZOLYL QUINOXALINE KINASE INHIBITORS
  申请人：Astex Therapeutics Limited

  公开号：EP3178818A1

  公开（公告）日：2017-06-14

  The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

  本发明涉及新的喹喔啉衍生物化合物、包含上述化合物的药物组合物、上述化合物的制备工艺以及上述化合物在治疗疾病（如癌症）中的应用。
• N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}HETEROCYCLYL AMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES
  申请人：Bayer Aktiengesellschaft

  公开号：EP3904349A2

  公开（公告）日：2021-11-03

  The present invention relates to N-(cyclopropylmethyl)-5-(methylsulfonyl)-N-1-[1-(pyrimidin-2-yl)-1H-1,2,4-triazol-5-yl]ethyl}heterocyclyl amide derivatives and related compounds of the general formula (I), wherein R2 is a heterocyclic ring, to formulations and compositions comprising such compounds and to their use in the control of animal pests including arthropods and insects in plant protection and to such compounds for use in controlling ectoparasites on animals.

  本发明涉及通式(I)的N-(环丙基甲基)-5-(甲磺酰基)-N-1-[1-(嘧啶-2-基)-1H-1,2,4-三唑-5-基]乙基}杂环酰胺衍生物及相关化合物，其中R2为杂环、包含此类化合物的制剂和组合物，以及它们在植物保护中用于控制动物害虫（包括节肢动物和昆虫）的用途，以及用于控制动物体外寄生虫的此类化合物。
• HERBIZID WIRKSAME 3-PHENYLISOXAZOLINDERIVATE
  申请人：Bayer CropScience AG

  公开号：EP2900645A1

  公开（公告）日：2015-08-05
• COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS
  申请人：Mironid Limited

  公开号：EP3519403B1

  公开（公告）日：2021-09-08
• ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDES
  申请人：OliPass Corporation

  公开号：US20190345202A1

  公开（公告）日：2019-11-14

  Provided are peptide nucleic acid derivatives targeting the 5′ splice site of “exon 5” within the human androgen receptor pre-mRNA. The peptide nucleic acid derivatives potently induce splice variants of the androgen receptor mRNA in cells, and are useful to safely treat dermatological indications or conditions involving androgenic activity upon topical administration.